OOIR: Observatory of International Research

Papers

(The H4-Index of Best Practice & Research Clinical Endocrinology & Metabolism is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Editorial Board	130
Editorial Board	88
Growth hormone replacement in adults with cured acromegaly: Efficacy and safety	81
Recent progress in molecular classification of phaeochromocytoma and paraganglioma	59
Editorial Board	57
The novel concept of “Onco-Immuno-Endocrinology” led to the discovery of new clinical entity “paraneoplastic autoimmune hypophysitis”	56
Gonadectomy in individuals with a difference of sex development – For whom, when, why, and why not?	56
Thiazide-induced hyponatremia	56
Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine	51
Genetics of pubertal timing	50
The role of androgens in transgender medicine	48
Polygenic risk scores for dyslipidemia and atherosclerotic cardiovascular disease: Progress toward clinical implementation	46
Coronavirus disease 2019 and vitamin D	44
Rare forms of genetic steroidogenic defects affecting the gonads and adrenals	38
Regulation of bone mass: A splendid Orchestra	37
Editorial Board	35
Sexual health and contraception in the menopause journey	35
Immune checkpoint inhibitor-related thyroid dysfunction	34
Editorial Board	31
Optimal surgical approach for digestive neuroendocrine neoplasia primaries: Oncological benefits versus short and long-term complications	31
Remnant lipoprotein particles and cardiovascular disease risk	30
Cardiometabolic outcomes of early onset hypogonadism in males	30
Haematological actions of androgens	29
Editorial Board	29
Medullary thyroid cancer - An update	27

Metabolic complications and their mechanisms in patients with craniopharyngioma	27
Non-oestrogen-based and complementary therapies for menopause	27
Type 1 diabetes related to immune checkpoint inhibitors	27